- Actemra may now be used to treat adults with giant cell arteritis — a chronic and potentially fatal autoimmune condition caused by inflammation of large and medium-sized arteries in the head or aorta.
- The Flourish Pediatric Esophageal Atresia device treats infants with esophageal atresia, a birth defect where the upper esophagus does not connect to the lower half of the esophagus and stomach.
- Kevzara is a biologic drug intended to treat patients with moderate to severe rheumatoid arthritis who do not respond to other treatments.
- Keytruda may now be used to treat solid cancer tumors that are inoperable or that have metastasized in patients with specific genetic biomarkers.
More articles on supply chain:
Ex-Heritage Pharma execs settle national price fixing lawsuit: 4 things to know
FDA on track to surpass total new drug approvals from 2016
6 must-reads for supply chain leaders this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
